Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine. - Wikidata - awgldk - TriplyDB

Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine.

Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine.

http://www.wikidata.org/entity/Q37325648

about

Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy A Clickable Analogue of Ketamine Retains NMDA Receptor Activity, Psychoactivity, and Accumulates in Neurons.Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.Organization, control and function of extrasynaptic NMDA receptors.Ketamine and phencyclidine: the good, the bad and the unexpected.New targets for rapid antidepressant action.Recent insights into the mode of action of memantine and ketamine Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation.Duality of Antidepressants and Neuroprotectants.Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial.Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking.Ketamine: NMDA Receptors and Beyond.Mechanical stress activates NMDA receptors in the absence of agonists ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression.Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function.Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.Short-Term Ketamine Treatment Decreases Oxidative Stress Without Influencing TRPM2 and TRPV1 Channel Gating in the Hippocampus and Dorsal Root Ganglion of Rats.

P2860

Q26770781-3FECA3CA-C746-4E22-81A3-429047EC7D95 Q26773084-4094A825-6E8D-45FC-8F46-CEF9C5FCF016 Q28817259-AB43507C-4060-4567-856C-C0C8D8CCCA83 Q30580921-59D4414D-0DB6-4E29-B225-01C91169A707 Q34236187-846DE87C-CA92-4F3C-9CCA-4E8BDE42E9DC Q34480719-6CED7D95-7906-4364-871F-C095C7093AB1 Q34507177-AE453D50-845D-4A75-AA3A-AA22F3EC6D95 Q35054539-1B2BFB28-7459-4618-AF09-8D4F53188295 Q35111472-72ADA5BD-8ABC-4A01-A0F6-273EE6249567 Q36323801-AE0FC9A6-1FA3-4B42-BD24-A4214D213AD3 Q36944840-E78C684D-6F51-42EF-A28D-6B1F5048B414 Q36998808-61687BEE-30D3-4861-BBA3-9A83D2C9768A Q37006341-7A41E79F-FD67-4693-B1CC-29B690B5D92F Q37490388-D5B48FAD-FBE8-496F-A9A7-1FCE9E1ED984 Q37550551-F872D019-440C-4D91-B58E-33C9C5A128D9 Q37583961-E9B99D55-9B0B-4032-BA84-15754938A1AA Q37644483-709ADFD4-E7B7-4619-BF02-A4B2C8EFD5B5 Q38254452-EB7ECC6A-226A-49FD-8AA7-D31189D44C94 Q38335068-184FA6AB-E69C-41AD-9C50-5DEAFCDFCC25 Q41926184-9576897F-78ED-414F-AD4A-12AC3B77462B Q47255869-8696B2CE-22D1-4C6B-959D-01CDD663B74E Q47583670-B51306BF-C294-4218-A346-59BB085A678C

P2860

Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine.

http://www.wikidata.org/entity/Q37325648

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Indistinguishable synaptic pha ...... ockers memantine and ketamine.

@en

Indistinguishable synaptic pha ...... ockers memantine and ketamine.

@nl

type

label

Indistinguishable synaptic pha ...... ockers memantine and ketamine.

@en

Indistinguishable synaptic pha ...... ockers memantine and ketamine.

@nl

prefLabel

Indistinguishable synaptic pha ...... ockers memantine and ketamine.

@en

Indistinguishable synaptic pha ...... ockers memantine and ketamine.

@nl

P1433

Q37325648-BEE9B848-8287-4AD2-AD27-9B66BEF3C23D

P1476

Q37325648-44674180-C22F-4282-A568-480CE9C2E1EB

P2093

Q37325648-277A766A-F70D-4F4C-AA40-4DC314E61F40

Q37325648-2F0C501C-036C-46F1-8331-37F81811057B

Q37325648-6A836B84-9A96-4419-94DE-BB9E03D6D198

Q37325648-B422262B-FAE8-4936-83ED-E921536F4B57

P2860

Q37325648-010D2191-CE9C-4B52-900E-B5A9275BBDDD

Q37325648-026CFECD-7DA1-4E3B-AAA3-BEB361891DE3

Q37325648-06E024A5-950A-45DF-9771-2EA7F2680C44

Q37325648-10E425F8-73D3-46C1-896D-AD38B6911EE1

Q37325648-1419C4CE-50AD-485E-8E7F-08A3F03B62C2

Q37325648-15A70FFA-5955-4288-9C83-DB0B2F4B66C5

Q37325648-17766997-4E1F-4D5B-A3FF-E260F08EE32A

Q37325648-1A5899E3-D0BF-4DB2-A85F-3AB1286AC943

Q37325648-2054912B-E977-41E2-8A15-51EA677EBD66

Q37325648-21FD732F-789D-4B6A-A980-246CD6932918

P304

Q37325648-B6694E20-EDC7-4E8F-AEEC-A82788382E88

P31

Q37325648-A6A3D4F8-DCCC-41B9-B582-956A458DA706

P356

Q37325648-91117984-708C-4BA7-8392-AEF1950FDDE8

P433

Q37325648-50C5882A-2FB5-48E6-80F0-B71509C4112F

P478

Q37325648-14AAB36D-7A22-4F5B-B635-433773F46D9B

P50

Q37325648-51B547C6-19CD-48D7-9F3A-FED08399DE90

Q37325648-F279194E-8254-4ADD-8D88-84571A56524B

P577

Q37325648-34D999FB-1965-4EC7-8F0D-F2D131D942A9

P5875

Q37325648-A5839462-B628-4368-B2E8-7031DF4C6A34

P698

Q37325648-87605CB5-AB28-470C-81D4-BFD9C415B581

P932

Q37325648-1E34CF59-09D7-4D52-B916-F29B8E3EAAB8

P356

P1433

Molecular Pharmacology

P1476

Indistinguishable synaptic pha ...... ockers memantine and ketamine.

@en

P2093

Amanda M Taylor

http://www.w3.org/2001/XMLSchema#string

Charles F Zorumski

http://www.w3.org/2001/XMLSchema#string

Lawrence N Eisenman

http://www.w3.org/2001/XMLSchema#string

Yukitoshi Izumi

http://www.w3.org/2001/XMLSchema#string

P2860

An extremely rich repertoire of bursting patterns during the development of cortical cultures

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade

Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses

Glutamate receptor ion channels: structure, regulation, and function

Transmitter release modulation by intracellular Ca2+ buffers in facilitating and depressing nerve terminals of pyramidal cells in layer 2/3 of the rat neocortex indicates a target cell-specific difference in presynaptic calcium dynamics

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Origin of variability in quantal size in cultured hippocampal neurons and hippocampal slices.

P304

935-947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/MOL.113.089334

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Steven Mennerick

Christine M Emnett

P577

2013-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257530975

http://www.w3.org/2001/XMLSchema#string

P698

24101301

http://www.w3.org/2001/XMLSchema#string

P932

3834148

http://www.w3.org/2001/XMLSchema#string